Causes and Mechanisms of Nondipping Hypertension

References

• Chobanian AC, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289: 2560–2572
   PubMed Web of Science ®Google Scholar
• O'Brien E, Sheridan J, O'Malley K. Dippers and nondippers. Lancet 1988; 2: 397
   PubMed Web of Science ®Google Scholar
• Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006; 354: 2368–2374
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Cavallini C. Ambulatory blood pressure for cardiovascular risk stratification. Circulation. 2007; 115: 2091–2093
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005; 111: 1777–1783
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999; 282: 539–546
   PubMed Web of Science ®Google Scholar
• Covic A, Goldsmith DJ. Ambulatory blood pressure monitoring in nephrology: Focus on BP variability. J Nephrol. 1999; 12: 220–229
   PubMed Web of Science ®Google Scholar
• Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: Technical aspects and clinical relevance. Curr Opin Nephrol Hypertens. 2002; 11: 507–516
   PubMed Web of Science ®Google Scholar
• Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in nondipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension. 1995; 26: 808–814
   PubMed Web of Science ®Google Scholar
• Ragot S, Herpin D, Siche JP, Ingrand P, Mallion JM. Autonomic nervous system activity in dipper and nondipper essential hypertensive patients. What about sex differences?. J Hypertens. 1999; 17: 1805–1811
   PubMed Web of Science ®Google Scholar
• Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y. Autonomic nervous system activity in essential hypertension: A comparison between dippers and nondippers. J Hum Hypertens. 1997; 11: 665–671
   PubMed Web of Science ®Google Scholar
• Fletcher AK, Weetman AP. Hypertension and hypothyroidism. J Hum Hypertens. 1998; 12: 79–82
   PubMed Web of Science ®Google Scholar
• Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid. 1996; 6: 505–512
   PubMed Web of Science ®Google Scholar
• Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg. 1997; 85: 734–738
   PubMed Web of Science ®Google Scholar
• Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A, Yigitoglu R, Covic A. Relation between serum thyroid hormone and “nondipper” circadian blood pressure variability. Kidney Blood Press Res. 2007; 30: 416–420
   PubMed Web of Science ®Google Scholar
• Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J. 2002; 143: 718–724
   PubMed Web of Science ®Google Scholar
• Ripoli A, Pingitore A, Favilli B, Bottoni A, Turchi S, Osman NF, De Marchi D, Lombardi M, L'Abbate A, Iervasi G. Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol. 2005; 45: 439–445
   PubMed Web of Science ®Google Scholar
• Richelsen B, Sorensen NS. Alpha 2- and beta-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism. 1987; 36: 1031–1039
   PubMed Web of Science ®Google Scholar
• Covic A, Mititiuc I, Gusbeth-Tatomir P, Goldsmith DJ. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment—a prospective ABPM study. J Nephrol. 2002; 15: 497–506
   PubMed Web of Science ®Google Scholar
• Letizia C, Ferrari P, Cotesta D, Caliumi C, Cianci R, Cerci S, Petramala L, Celi M, Minisola S, D'Erasmo E, Mazzuoli GF. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J Hum Hypertens. 2005; 19: 901–906
   PubMed Web of Science ®Google Scholar
• Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan R, Uz E, Bavbek N, Yigitoglu R, Covic A. Relation between serum calcium, phosphate, parathyroid hormone and “nondipper” circadian blood pressure variability profile in patients with normal renal function. American Journal of Nephrology. 2007; 27: 516–521
   PubMed Web of Science ®Google Scholar
• Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium  ×  phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998; 31: 607–617
   PubMed Web of Science ®Google Scholar
• Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, Ritz E. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant. 1997; 12: 933–938
   PubMed Web of Science ®Google Scholar
• Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005; 288: E125–E132
   PubMed Web of Science ®Google Scholar
• Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89–90: 387–392
   PubMed Web of Science ®Google Scholar
• Imai Y, Abe K, Sasaki S, Minami N, Nihei M, Munakata M, Murakami O, Matsue K, Sekino H, Miura Y, Yoshioka K. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension. 1988; 12: 11–19
   PubMed Web of Science ®Google Scholar
• Zacharieva S, Orbetzova M, Stoynev A, Shigarminova R, Yaneva M, Kalinov K, Nachev E, Elenkova A. Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment. J Endocrinol Invest. 2004; 27: 924–930
   PubMed Web of Science ®Google Scholar
• Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in nondipper hypertensive patients. Blood Pressure. 2003; 12: 19–24
   PubMed Web of Science ®Google Scholar
• Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and nondipping blood pressure profile. Life Sci. 2005; 76: 1795–1803
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Schnack C, Mittermayer F, Kopp HP, Hofer M, Kann T, Schernthaner G. High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism. Exp Clin Endocrinol Diabetes. 2005; 113: 430–434
   PubMed Web of Science ®Google Scholar
• Pietrobelli DJ, Akopian M, Olivieri AO, Renauld A, Garrido D, Artese R, Feldstein CA. Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values. J Hum Hypertens. 2001; 15: 601–605
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Imai Y, Ohkubo T, Tsuji I, Nagai K, Kikuchi N, Kato J, Sekino M, Aihara A, Kikuya M, Satoh H, Hisamichi S. Determinants of circadian blood pressure variation: A community-based study in Ohasama. Tohoku J Exp Med. 1997; 183: 1–20
   PubMed Web of Science ®Google Scholar
• Fagard R, Staessen JA, Thijs L. The relationships between left ventricular mass and daytime and night-time blood pressures: A meta-analysis of comparative studies. J Hypertens. 1995; 13: 823–829
   PubMed Web of Science ®Google Scholar
• Kamide K, Kawano Y. Age related hemodynamic changes in the elderly. Nippon Rinsho. 2005; 63: 969–972
   PubMedGoogle Scholar
• Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol. 1978; 274: 621–637
   PubMed Web of Science ®Google Scholar
• Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Consequences of impaired arterial baroreflexes in essential hypertension: Effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens. 1988; 6: 525–535
   PubMed Web of Science ®Google Scholar
• Osanai T, Okuguchi T, Kamada T, et al. Salt-induced exacerbation of morning surge in blood pressure in patients with essential hypertension. J Hum Hypertens. 2000; 14: 57–64
   PubMed Web of Science ®Google Scholar
• Uzu T, Ishikawa K, Fujii T, et al. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997; 96: 1859–1862
   PubMed Web of Science ®Google Scholar
• Wilson DK, Sica DA, Miller SB. Effects of potassium on blood pressure in salt-sensitive and salt-resistant adolescents. Hypertension. 1999; 34: 181–186
   PubMed Web of Science ®Google Scholar
• Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropahty, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care. 1994; 17: 578–584
   PubMed Web of Science ®Google Scholar
• Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Battle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002; 347: 797–805
   PubMed Web of Science ®Google Scholar
• Mulec H, Blohme G, Kullenberg K, Nyberg G, Bjorck S. Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia. 1995; 38: 216–220
   PubMed Web of Science ®Google Scholar
• Banskota NK, Taub R, Zellner K, Olsen P, King G. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells in insulin and IGF-1. Diabetes. 1989; 38: 123–129
   PubMed Web of Science ®Google Scholar
• Tartan Z, Uyarel H, Kasikcioglu H, Alper AT, Ozay B, Bilsel T, Gul M, Ozturk R, Cam N. Metabolic syndrome as a predictor of nondipping hypertension. Tohoku J Exp Med. 2006; 210: 57–66
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985; 75: 809–817
   PubMed Web of Science ®Google Scholar
• Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989; 2: 419–423
   PubMed Web of Science ®Google Scholar
• Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, Fallo F. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am J Hypertens. 2005; 18: 30–35
   PubMed Web of Science ®Google Scholar
• Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: The Fredericia Study. Diabetes Care. 2000; 23: 283–289
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Sala C, Magrini F, Zanchetti A. Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome?. Blood Press. 2004; 13: 230–235
   PubMed Web of Science ®Google Scholar
• Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Intern Med. 1967; 67: 48–59
   PubMed Web of Science ®Google Scholar
• Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension: A review. Circulation. 1969; 39: 403–421
   PubMed Web of Science ®Google Scholar
• Reisin E, Messerli FG, Ventura HO, Frohlich ED. Renal haemodynamic studies in obesity hypertension. J Hypertens. 1987; 5: 397–400
   PubMed Web of Science ®Google Scholar
• Krieger DR, Landsberg L. Mechanisms in obesity-related hypertension: Role of insulin and catecholamines. Am J Hypertens. 1988; 1: 84–90
   PubMed Web of Science ®Google Scholar
• Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med. 1978; 298: 1295–1301
   PubMed Web of Science ®Google Scholar
• Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation. 1994; 89: 2634–2640
   PubMed Web of Science ®Google Scholar
• Antic V, Van Vliet BN, Montani JP. Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits. Auton Neurosci. 2001; 90: 152–157
   PubMed Web of Science ®Google Scholar
• Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, Meydrech EF, Mizelle HL. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol. 1996; 271: H373–H378
   PubMed Web of Science ®Google Scholar
• Antic V, Tempini A, Montani JP. Serial changes in cardiovascular and renal function of rabbits ingesting a high-fat, high-calorie diet. Am J Hypertens. 1999; 12: 826–829
   PubMed Web of Science ®Google Scholar
• Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991; 87: 2246–2252
   PubMed Web of Science ®Google Scholar
• Afsar B, Sezer S, Elsurer R, Ozdemir FN. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?. Blood Press Monit. 2007; 12: 133–139
   PubMed Web of Science ®Google Scholar
• Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uremia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997; 12: 2301–2307
   PubMed Web of Science ®Google Scholar
• Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: Technical aspects and clinical relevance. Curr Opin Nephrol Hypertens. 2002; 11: 507–516
   PubMed Web of Science ®Google Scholar
• London GM, Guerin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996; 50: 600–608
   PubMed Web of Science ®Google Scholar
• Liu M, Takahashi H, Morita Y, Maruyama S, Mizuno M, Yuzawa Y, Watanabe M, Toriyama T, Kawahara H, Matsuo S. Nondipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 563–569
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Tripepi G, et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int. 1998; 53: 1078–1084
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G, et al. Autonomic neuropathy is linked to nocturnal hypoxemia and to concentric hypertrophy and remodeling in dialysis patients. Nephrol Dial Transplant. 2001; 16: 70–77
   PubMed Web of Science ®Google Scholar
• Mansoor GA, White WB. Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. Hypertension. 1998; 31: 843–847
   PubMed Web of Science ®Google Scholar
• Lund-Johansen P, White WB. Central hemodynamics and 24-hour blood pressure in obstructive sleep apnea syndrome: Effects of corrective surgery. Am J Med. 1990; 88: 678–682
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic 28. Neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995; 96: 1897–1904
   PubMed Web of Science ®Google Scholar
• Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, Iorio M, De Toma G, Ciardi A, Vitolo D, Letizia C. Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens (Greenwich). 2006; 8: 642–648
   PubMedGoogle Scholar
• Penzo M, Palatini P, Rossi GP, Zanin L, Pessina AC. In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension. Clin Exp Hypertens. 1994; 16: 659–673
   PubMed Web of Science ®Google Scholar
• Spieker C, Barenbrock M, Rahn KH, Zidek W. Circadian blood pressure variations in endocrine disorders. Blood Press. 1993; 2: 35–39
   PubMedGoogle Scholar
• Zelinka T, Strauch B, Pecen L, Widimsky J, Jr. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 2004; 18: 107–111
   PubMed Web of Science ®Google Scholar
• Zelinka T, Strauch B, Petrak O, Holaj R, Vrankova A, Weisserova H, Pacak K, Widimsky J, Jr. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens. 2005; 23: 2033–2039
   PubMed Web of Science ®Google Scholar
• Young T, Peppard P, Palta M, la KM H, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997; 157: 1746–1752
   PubMed Web of Science ®Google Scholar
• Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet. 1991; 338: 1480–1484
   PubMed Web of Science ®Google Scholar
• Koskenvuo M, Kaprio J, Partinen M, Langinvanio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985; 1: 89–95
   PubMed Web of Science ®Google Scholar
• Hung J, Whitford EG, Parsons RW, Hillman RW. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990; 336: 261–264
   PubMed Web of Science ®Google Scholar
• Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996; 27: 401–407
   PubMed Web of Science ®Google Scholar
• Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest. 1990; 97: 27–32
   PubMed Web of Science ®Google Scholar
• Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999; 17: 61–66
   PubMed Web of Science ®Google Scholar
• Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea: Response to CPAP therapy. Thorax. 2000; 55: 1046–1051
   PubMed Web of Science ®Google Scholar
• Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998; 98: 1071–1077
   PubMed Web of Science ®Google Scholar
• Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest. 2001; 120: 887–893
   PubMed Web of Science ®Google Scholar
• Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: A placebo trial. Hypertension. 2000; 35: 144–147
   PubMed Web of Science ®Google Scholar
• Asplund R. Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int. 2005; 96: 15–21
   PubMed Web of Science ®Google Scholar
• Bao X, Nelesen RA, Loredo JS, Dimsdale JE, Ziegler MG. Blood pressure variability in obstructive sleep apnea: Role of sympathetic nervous activity and effect of continuous positive airway pressure. Blood Press Monit. 2002; 7: 301–307
   PubMed Web of Science ®Google Scholar
• Natsume O. A clinical investigation of nocturnal polyuria in patients with nocturia: A diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure. J Urol. 2006; 176: 660–664
   PubMed Web of Science ®Google Scholar
• Turgut F, Bayrak O, Kanbay M, Ozkara A, Uz E, Bavbek N, Kargili A, Akcay A. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scand J Urol Nephrol. 2008; 42: 47–52
   PubMed Web of Science ®Google Scholar
• Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol. 2004; 172: 1390–1393
   PubMed Web of Science ®Google Scholar
• McVary KT, Rademaker A, Lloyd GL, Gann P. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2005; 174: 1327–1333
   PubMed Web of Science ®Google Scholar
• J ossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M. Serum uric acid and hypertension: The Olivetti Heart Study. J Hum Hypertens. 1994; 8: 677–681
   PubMed Web of Science ®Google Scholar
• Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 45: 28–33
   PubMed Web of Science ®Google Scholar
• Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007; 39: 1227–1233
   PubMed Web of Science ®Google Scholar
• Morillo MG, Amato MC, Cendon Filha SP. Twenty-four hour blood pressure record for smokers and nonsmokers. Arq Bras Cardiol. 2006; 87: 504–511
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Calvo C. Optimal timing for antihypertensive dosing: Focus on valsartan. Ther Clin Risk Manag. 2007 Mar; 3(1)119–131
   PubMedGoogle Scholar